Skip to content
← Back to this collection

PUBLICATIONS · 15238420

Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2004 Nov 1
First author
Lenz G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lenz G
      type
      Author
    2. name
      Dreyling M
      type
      Author
    3. name
      Schiegnitz E
      type
      Author
    4. name
      Forstpointner R
      type
      Author
    5. name
      Wandt H
      type
      Author
    6. name
      Freund M
      type
      Author
    7. name
      Hess G
      type
      Author
    8. name
      Truemper L
      type
      Author
    9. name
      Diehl V
      type
      Author
    10. name
      Kropff M
      type
      Author
    11. name
      Kneba M
      type
      Author
    12. name
      Schmitz N
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lenz G
      type
      Author
    2. name
      Dreyling M
      type
      Author
    3. name
      Schiegnitz E
      type
      Author
    4. name
      Forstpointner R
      type
      Author
    5. name
      Wandt H
      type
      Author
    6. name
      Freund M
      type
      Author
    7. name
      Hess G
      type
      Author
    8. name
      Truemper L
      type
      Author
    9. name
      Diehl V
      type
      Author
    10. name
      Kropff M
      type
      Author
    11. name
      Kneba M
      type
      Author
    12. name
      Schmitz N
      type
      Author
    bibliography ids
    1. nci-bib-d7aa2ab88191e5db852b8ccb
    book metadata
    content sha256
    1f3d9f3229c8a550cff73316f253b66ca4e9b56132429bb7908a596e9c3fa56e
    document type
    citation
    dois
    1. 10.1182/blood-2004-03-0982
    electronic publication date
    display
    2004 Jul 6
    precision
    day
    year
    2004
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:15238420
    immutable id
    pubmed:15238420@1f3d9f3229c8a550cff73316f253b66ca4e9b56132429bb7908a596e9c3fa56e
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    9
    name
    Blood
    nlm unique id
    7603509
    pages
    2667-74
    volume
    104
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      15238420
      provenance
      batch id
      748437a772c9631ad901
      provider
      NCBI PubMed ESummary
      record sha256
      61ef98a635fcf2548f7023a7c375615b9f6a8ff77057e7bc933538d16aa3acd5
      response sha256
      1535c16de1ca2ef53b01ccf9e7709049035aa1b159955f06fbec3d1a0daddc80
      retrieved at
      2026-09-09T23:45:55.399079+00:00
      publication date
      display
      2004 Nov 1
      precision
      day
      year
      2004
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/15238420/
      title
      Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.

      Preserved source evidence · Independent clinical review pending · Not medical advice